In New Jersey, cosmetic surgery tax raised funds far below projections

NewsGuard 100/100 Score
Bloomberg: "A tax on breast enhancements and other cosmetic care, similar to one proposed in the U.S. Senate's health-overhaul legislation, doesn't generate even a third of the $30 million a year originally projected for it in New Jersey, the only state with such a levy."

That state's program, which began in 2004, "grossed about $9 million last year (far short of the $30 million it was supposed to raise per year), according to data from the state's legislative services office." That amount doesn't factor in the "cost of administering the 6 percent levy, which the office doesn't have figures on." An assemblyman in New Jersey who sponsored the legislation and now wants it repealed said the tax ended up discouraging cosmetic care in the state. "In the U.S., about 12 million people spent $10.3 billion in 2008 on cosmetic procedures and products, according to the American Society of Plastic Surgeons, based in Arlington Heights, Illinois" (Gaouette, 12/7).

Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
What does the future hold for obesity medication development?